Sovateltide (IRL-1620) activates neuronal differentiation and prevents mitochondrial dysfunction in adult mammalian brains following stroke

Centhaquine can provide hemodynamic stability, improve tissue oxygenation, reduce pulmonary edema, acute respiratory distress syndrome (ARDS), multiple organ dysfunction score (MODS) and mortality in coronavirus disease 2019 (COVID-19) patients

WILLOWBROOK, Ill., April 9, 2020 /PRNewswire/ — Pharmazz, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat patients in critical care, today announced that centhaquine, a drug in final stage of...